Moreover, loss or downregulation of E‐cadherin has been observed in several metastatic breast cancer cell lines and breast carcinomas (Sommers et al., 1994) and has been correlated with an epithelial‐to‐mesenchymal (EMT) phenotype (Thiery and Sleeman, 2006). This evidence concerns the gene CDH1 and breast carcinoma.